Cancer BiologybioRxivPreprint
MAT2A inhibition in AML unveils therapeutic potential of combining DNA demethylating agents with UPR targeting
K. Zeka, A. V. Taylor, R. Samarista…·C. Pina
The paper shows that combining DNA demethylating agents with UPR targeting improves AML cell suppression beyond single-agent therapies.
DOI 10.1101/2023.06.05.543499